enVVeno Medical Corp Operating Income

Quick Answer

enVVeno Medical Corp reported Operating Income of -$20.90 million for fiscal year 2025.

enVVeno Medical Corp Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 -$20.90M +12.3%
2024 -$23.83M +5.6%
2023 -$25.24M -1.2%
2022 -$24.93M -47.6%
2021 -$16.89M -84.9%
2020 -$9.14M -19.0%
2019 -$7.68M +2.3%
2018 -$7.85M -28.7%
2017 -$6.10M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
September 30, 2025 -$4.88M +20.9% +30.7%
June 30, 2025 -$7.05M -29.2% -42.3%
March 31, 2025 -$4.95M +10.0% +19.7%
September 30, 2024 -$6.17M -15.3% -13.1%
June 30, 2024 -$5.45M +20.0% +0.9%
March 31, 2024 -$5.50M +19.0% -2.9%
September 30, 2023 -$5.35M +13.0% +21.5%
June 30, 2023 -$6.81M +2.5% -0.3%
  • enVVeno Medical Corp showed an increase of +12.3% in Operating Income compared to the prior fiscal year.
  • Over the 2017–2025 period, enVVeno Medical Corp’s operating income has declined by 242.4% (from -$6.10 million to -$20.90 million).
  • The most recent figure is from enVVeno Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment